Tech Company Financing Transactions

Accuri Cytometers Funding Round

Arboretum Ventures, Baird Capital and F-Prime Capital invested in a $6 million Series E funding round for Accuri Cytometers. The funding round closed on 7/12/2010.

Transaction Overview

Company Name
Announced On
7/12/2010
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series E
Investors

Arboretum Ventures (Timothy Petersen)

Baird Capital (Peter Shagory)

F-Prime Capital (Robert Weisskoff)

Flagship Pioneering (Harry Wilcox)

Proceeds Purpose
Accuri plans to use the proceeds from the Series E financing to support expansion of the Accuri C6 Flow Cytometer® System into the clinical in vitro diagnostics (IVD) market.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
173 Parkland Plaza
Ann Arbor, MI 48103
USA
Email Address
Overview
Accuri Cytometers Inc. is an Ann-Arbor based life sciences company developing revolutionary high performance cell analysis systems designed to bring the power of flow cytometry into the labs of life sciences researchers everywhere.
Profile
Accuri Cytometers LinkedIn Company Profile
Social Media
Accuri Cytometers Company Twitter Account
Company News
Accuri Cytometers News
Facebook
Accuri Cytometers on Facebook
YouTube
Accuri Cytometers on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Williams
  Jeffrey Williams LinkedIn Profile  Jeffrey Williams Twitter Account  Jeffrey Williams News  Jeffrey Williams on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/12/2010: NuOrtho Surgical venture capital transaction
Next: 7/12/2010: iLevel Solutions venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary